StonvexLoading…
StonvexStonvexStonvexCore line items from IR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.85B | $7.65B | $5.56B | $3.60B |
Operating Income | $289.70M | $1.14B | $754.40M | $378.90M |
Net Income | $192.10M | $581.40M | $315.30M | $71.20M |
EPS (Diluted) | $0.49 | $1.45 | $0.78 | $0.18 |
Total Assets | $18.22B | $18.30B | $18.19B | $18.06B |
Total Liabilities | $7.98B | $8.14B | $8.00B | $7.90B |
Cash & Equivalents | $1.27B | $1.25B | $1.18B | $1.31B |
Free Cash Flow OCF − CapEx | $163.40M | $1.22B | $758.60M | $433.10M |
Shares Outstanding | 394.00M | 391.12M | 402.90M | 404.90M |